Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 422
Filter
1.
Arq. bras. cardiol ; 118(1): 68-74, jan. 2022. tab
Article in English, Portuguese | LILACS | ID: biblio-1360106

ABSTRACT

Resumo Fundamento Apesar da grande proporção de octogenários com embolia pulmonar aguda, há pouca informação indicando a estratégia de manejo ideal, especialmente medidas terapêuticas, como a terapia lítica. Objetivos O número de pacientes idosos diagnosticados com embolia pulmonar aguda aumenta constantemente. Porém, o papel do tratamento trombolítico não está claramente definido entre os octogenários. Nosso objetivo é avaliar a efetividade da terapia lítica em pacientes octogenários diagnosticados com embolia pulmonar. Métodos Cento e quarenta e oito indivíduos (70,3% de mulheres, n=104) com mais de 80 anos foram incluídos no estudo. Os pacientes foram divididos em dois grupos: tratamento trombolítico versus não-trombolítico. As taxas de mortalidade hospitalar e episódios de sangramento foram definidos como desfechos do estudo. Valor de p <0,05 foi considerado como estatisticamente significativo. Resultados A mortalidade hospitalar reduziu significativamente no grupo trombolítico em comparação ao não-trombolítico (10,5% vs. 24,2%; p=0,03). Episódios de sangramento menores foram mais comuns no braço que recebeu o tratamento trombolítico, mas grandes hemorragias não diferiram entre os grupos (35,1% vs. 13,2%, p<0,01; 7% vs. 5,5% p=0,71, respectivamente). O escore de PESI alto (OR: 1,03 IC95%; 1,01-1,04 p<0,01), a terapia trombolítica (OR: 0,15 IC95%; 0,01-0,25, p< 0,01) e níveis altos de troponina (OR: 1,20 IC95%; 1,01-1,43, p=0,03) estiveram independentemente associados a taxas de mortalidade hospitalar na análise de regressão multivariada. Conclusão A terapia trombolítica esteve associada à mortalidade hospitalar reduzida em detrimento do aumento geral das complicações de sangramento em octogenários.


Abstract Background Despite the high proportion of octogenarians with acute pulmonary embolism, there is little information indicating the optimal management strategy, mainly therapeutic measures, such as lytic therapy. Objectives The number of elderly patients diagnosed with acute pulmonary embolism increases constantly. However, the role of thrombolytic treatment is not clearly defined among octogenarians. Our objective is to evaluate the effectiveness of lytic therapy in octogenarian patients diagnosed with pulmonary embolism. Methods One hundred and forty eight subjects (70.3% women, n=104) aged more than eighty years were included in the study. The patients were divided in two groups: thrombolytic versus non-thrombolytic treatment. In-hospital mortality rates and bleeding events were defined as study outcomes. P-value <0.05 was considered as statistical significance. Results In-hospital mortality decreased significantly in the thrombolytic group compared to the non-thrombolytic group (10.5% vs. 24.2% p=0.03). Minor bleeding events were more common in the arm that received thrombolytic treatment, but major hemorrhage did not differ between the groups (35.1% vs. 13.2%, p<0.01; 7% vs. 5.5% p=0.71, respectively). High PESI score (OR: 1.03 95%CI; 1.01-1.04 p<0.01), thrombolytic therapy (OR: 0.15 95%CI; 0.01-0.25, p< 0.01) and high troponin levels (OR: 1.20 95%CI; 1.01-1.43, p=0.03) were independently associated with in-hospital mortality rates in the multivariate regression analysis. Conclusion Thrombolytic therapy was associated with reduced in-hospital mortality at the expense of increased overall bleeding complications in octogenarians.


Subject(s)
Humans , Child , Adolescent , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Metabolic Syndrome/epidemiology , Pediatric Obesity/therapy , Body Composition , Weight Loss/physiology , Body Mass Index , Atrial Natriuretic Factor/metabolism
2.
Arq. bras. cardiol ; 118(1): 33-40, jan. 2022. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1360114

ABSTRACT

Resumo Fundamento A ação do peptídeo natriurético atrial (ANP) na natriurese, diurese e vasodilatação, resistência à insulina, fígado, rim e tecido adiposo pode contribuir para o desenvolvimento metabólico e cardiovascular saudável. Embora o nível circulante de ANP seja reduzido em pacientes com obesidade, sua resposta à perda de peso ainda é pouco explorada em populações pediátricas. Objetivo Avaliar os efeitos das variações do ANP em resposta à intervenção interdisciplinar para perda de peso na Síndrome Metabólica (SMet) e nos riscos cardiometabólicos em adolescentes com obesidade. Métodos 73 adolescentes com obesidade participaram de uma terapia interdisciplinar para perda de peso de 20 semanas, incluindo uma abordagem clínica, nutricional, psicológica e de exercícios físicos. A composição corporal, análises bioquímicas e pressão sanguínea foram avaliadas. A SMet foi classificada de acordo com a Federação Internacional de Diabetes (IDF) (2007). Após o tratamento, os voluntários foram divididos de acordo com os níveis de plasma do ANP aumento (n=31) ou ANP redução (n=19). Resultados Ambos os grupos apresentaram redução significativa de peso corporal, índice de massa corporal (IMC) e circunferências de cintura, pescoço e quadril (CC, CP e CQ, respectivamente), e aumento da massa livre de gordura (MLG). É interessante observar que houve uma redução significativa na gordura corporal, na razão de TG/HDL-c e na prevalência de SMet (de 23% para 6%) somente no grupo com ANP aumento. Conclusão Este estudo sugere que o aumento nos níveis séricos de ANP após a terapia para perda de peso pode estar associado a melhorias nos riscos cardiometabólicos e na prevalência reduzida de SMet em adolescentes com obesidade.


Abstract Background The action of atrial natriuretic peptide (ANP) on natriuresis, diuresis and vasodilatation, insulin resistance, liver, kidney, and adipose tissue may contribute to the healthy metabolic and cardiovascular development. Even though the circulating level of ANP is reduced in patients with obesity, its response to weight loss remains poorly explored in pediatric populations. Objective To evaluate the effects of ANP variations in response to interdisciplinary weight loss intervention on metabolic syndrome (MetS) and cardiometabolic risks in adolescents with obesity. Methods 73 adolescents with obesity attended a 20-week clinical interdisciplinary weight loss therapy including clinical, nutritional, psychological and exercise training approach. Body composition, biochemical analyses and blood pressure were evaluated. MetS was classified according to the International Diabetes Federation (IDF) (2007). After the treatment, volunteers were divided according to Increasing (n=31) or Decreasing (n=19) ANP plasma levels. Results Both groups present significant reduction of body weight, Body Mass Index (BMI), waist, neck and hip circumferences (WC, NC and HC, respectively) and increasing fat-free mass (FFM). Interestingly, a significant reduction in body fat, TG/HDL-c ratio and MetS prevalence (from 23% to 6%) was observed in the Increased ANP group only. Conclusion This study suggests that an increase in ANP serum levels after weight loss therapy could be associated with improvements in cardiometabolic risks and the reduced prevalence of MetS in adolescents with obesity.


Subject(s)
Humans , Child , Adolescent , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Metabolic Syndrome/epidemiology , Pediatric Obesity/therapy , Body Composition , Weight Loss/physiology , Body Mass Index , Atrial Natriuretic Factor/metabolism
4.
Rev. Assoc. Med. Bras. (1992) ; 67(7): 918-925, July 2021. tab, graf
Article in English | LILACS | ID: biblio-1346950

ABSTRACT

SUMMARY OBJECTIVE: To verify the association between metabolic syndrome and its components, and intake of antioxidant nutrients in adolescents. METHODS: This is a cross-sectional study of the data of 327 adolescents in a high school in Teresina, Piauí, Brazil, pertaining to their socioeconomic background, anthropometric measurements, dietary intake (selenium; copper; zinc; vitamins A, C, and E), hemodynamics, and biochemical tests. The criteria for diagnosing metabolic syndrome in adolescents were applied. Binary logistic regression was used to verify the association between metabolic syndrome and its components, and intake of antioxidants. The level of significance was established at p<0.05. RESULTS: Prevalence of metabolic syndrome was 7.0%, with a significant association between body mass index and blood pressure. Lower tertiles of copper and vitamins A and E intake were associated with high triglyceride and glycemic levels. The association with vitamins A and E remained after adjustment. CONCLUSIONS: A significant association between lower vitamins A and E intake and metabolic syndrome components (altered triglycerides and glycemic levels) was found. Besides further studies on this issue, the need for health interventions was found, which ensures the appropriate intake of antioxidant nutrients during adolescence.


Subject(s)
Humans , Adolescent , Metabolic Syndrome/epidemiology , Antioxidants , Energy Intake , Cross-Sectional Studies , Diet , Eating
5.
Article in English | WPRIM | ID: wpr-887738

ABSTRACT

Objective@#This study aims to assess the dose-response relationship between serum ferritin (SF) and metabolic syndrome (MetS) in the two sexes.@*Methods@#We searched for articles on PubMed, the Cochrane Library, EMBASE, and the Web of Science databases that were published from 1950 to 2020. The summary odds ratio ( @*Results@#This study included 14 studies and 74,710 samples. The results of the classical meta-analysis showed that SF was positively associated with MetS ( @*Conclusions@#Our study shows that SF is significantly and positively associated with MetS, and the risk in the male population is higher than that in the female population. This finding also supports the recommendation of using SF as an early warning marker of MetS.


Subject(s)
Biomarkers/blood , Female , Ferritins/blood , Humans , Male , Metabolic Syndrome/epidemiology , Risk Factors , Sex Characteristics
6.
Acta Paul. Enferm. (Online) ; 34: eAPE00625, 2021. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1349861

ABSTRACT

Resumo Objetivo Identificar a prevalência da síndrome metabólica e a concordância entre os critérios do National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) e da International Diabetes Federation (IDF) em pessoas vivendo com HIV. Métodos Estudo analítico transversal, realizado em cinco serviços especializados em município do interior paulista, de 2014 a 2016, com 340 pessoas vivendo com HIV. Variáveis sociodemográficas e clínicas necessárias para classificação da síndrome metabólica pelos critérios do NCEP-ATPIII e da IDF foram coletadas por meio de entrevistas. Para avaliar a concordância entre os critérios da SM, NCEP-ATPIII e IDF, foi utilizada a estatística first-order agreement coefficient. Para verificar a relação entre a síndrome metabólica e as variáveis do estudo, utilizou-se a regressão de Poisson com variância robusta. Resultados A prevalência da síndrome metabólica foi de 28,5% pelo critério NCEP-ATPIII e 39,3% IDF. As maiores prevalências foram associadas ao sexo feminino e faixas etárias a partir dos 50 anos, enquanto que, no tempo de diagnóstico entre 2 a 10 anos, prevalências menores. A concordância entre os dois critérios foi considerada substancial. Conclusão A concordância substancial entre os critérios IDF e NCEP-ATPIII sugere a possibilidade de intercambio entre eles. Ademais, os resultados sinalizam para a necessidade de atenção especial dos serviços para a avaliação do perfil metabólico e identificação das pessoas vivendo com HIV que possuem alto risco cardiovascular.


Resumen Objetivo Identificar la prevalencia del síndrome metabólico y la concordancia entre los criterios del National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) y de la International Diabetes Federation (IDF) en personas que viven con el VIH. Métodos Estudio analítico transversal, realizado en cinco servicios especializados en un municipio del interior del estado de São Paulo, de 2014 a 2016, con 340 personas que viven con el VIH. Por medio de entrevistas se recopilaron las variables sociodemográficas y clínicas necesarias para la clasificación del síndrome metabólico mediante los criterios del NCEP-ATPIII y de la IDF. Para evaluar la concordancia entre los criterios del SM, NCEP-ATPIII e IDF, se utilizó la estadística first-order agreement coefficient. Para verificar la relación entre el síndrome metabólico y las variables del estudio, se utilizó la regresión de Poisson con varianza robusta. Resultados La prevalencia del síndrome metabólico fue del 28,5 % mediante el criterio NCEP-ATPIII y 39,3 % por la IDF. Las mayores prevalencias se asociaron al sexo femenino y los grupos de edad a partir de los 50 años, mientras que hubo prevalencias menores en el tiempo de diagnóstico entre 2 y 10 años. La concordancia entre los dos criterios fue considerada sustancial. Conclusión La concordancia sustancial entre los criterios IDF y NCEP-ATPIII sugiere la posibilidad de intercambio entre ellos. Además, los resultados señalan la necesidad de una atención especial de los servicios para evaluar el perfil metabólico e identificar a las personas que viven con el VIH con alto riesgo cardiovascular.


Abstract Objective To identify the prevalence of metabolic syndrome and the agreement between the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) and the International Diabetes Federation (IDF) in people living with HIV. Methods This is a cross-sectional analytical study, carried out in five specialized services in a city in the interior of São Paulo, from 2014 to 2016, with 340 people living with HIV. Sociodemographic and clinical variables necessary for classification of the metabolic syndrome by the NCEP-ATPIII and IDF criteria were collected through interviews. To assess the agreement between MS, NCEP-ATPIII and IDF criteria, the first-order agreement coefficient statistic was used. To verify the relationship between the metabolic syndrome and the study variables, Poisson regression with robust variance was used. Results The prevalence of metabolic syndrome was 28.5% by the NCEP-ATPIII criterion and 39.3% IDF. The highest prevalence was associated with females and age groups from 50 years old, while, in the time of diagnosis between 2 and 10 years, lower prevalence. The agreement between the two criteria was considered substantial. Conclusion The substantial agreement between the IDF and NCEP-ATPIII criteria suggests the possibility of interchange between them. Moreover, the results signal the need for special attention from services for the assessment of the metabolic profile and identification of people living with HIV who are at high cardiovascular risk.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Acquired Immunodeficiency Syndrome/drug therapy , HIV/drug effects , Antiretroviral Therapy, Highly Active/adverse effects , Metabolic Syndrome/epidemiology , Cross-Sectional Studies , Interviews as Topic
7.
Esc. Anna Nery Rev. Enferm ; 25(1): e20200055, 2021. tab, graf
Article in Portuguese | LILACS, BDENF | ID: biblio-1114764

ABSTRACT

RESUMO Objetivo avaliar a síndrome metabólica e o risco cardiovascular de idosos hipertensos atendidos na atenção primária. Métodos estudo transversal realizado com 154 idosos hipertensos de uma Unidade Básica de Saúde do Distrito Federal. Um instrumento estruturado investigou o perfil dos idosos. Para a classificação da síndrome metabólica, consideraram-se os critérios propostos pela National Cholesterol Education Program - Adult Treatment Panel III. Para análise do risco cardiovascular, utilizou-se o escore de risco de Framingham. Foi realizada análise estatística e inferencial com a utilização da ANOVA, teste qui-quadrado e exato de Fisher, além da odds ratio e seu intervalo de confiança de 95% para estimar o risco cardiovascular entre os grupos. Resultados 64,9% dos idosos hipertensos eram obesos. Síndrome metabólica foi evidenciada em 70,8%. Observou-se que 27,2% apresentaram baixo, 46,8% moderado e 26,0% elevado risco cardiovascular, sendo que o sexo feminino e a idade avançada influenciaram negativamente o risco. Idosos com síndrome metabólica apresentaram 7,19 vezes mais chances de terem elevado risco cardiovascular. Considerações finais e implicações para a prática os idosos hipertensos apresentaram uma elevada prevalência de síndrome metabólica que aumentou significativamente o risco cardiovascular. Este resultado possibilita um melhor planejamento da assistência de enfermagem pelo enfermeiro da atenção primária à saúde.


RESUMEN Objetivo evaluar el síndrome metabólico y el riesgo cardiovascular de pacientes hipertensos de la tercera edad tratados en la atención primaria. Métodos estudio transversal realizado con 154 personas de la tercera edad hipertensas de una Unidad Básica de Salud del Distrito Federal. Se investigó el perfil de estas personas a través de un instrumento estructurado. Para clasificar el síndrome metabólico se utilizaron los criterios propuestos por el National Cholesterol Education Program - Adult Treatment Panel III. Para analizar el riesgo cardiovascular, se utilizó el escore de riesgo de Framingham. El análisis estadístico e inferencial se realizó mediante ANOVA, chi-cuadrado y la prueba exacta de Fisher, además de la odds ratio y su intervalo de confianza del 95% para estimar el riesgo cardiovascular entre los grupos. Resultados el 64,9% de las personas hipertensas de la tercera edad eran obesas. El síndrome metabólico se observó en el 70,8% de los casos. Se pudo observar que el 27,2% eran de riesgo cardiovascular bajo, 46,8% moderado y 26,0% alto, siendo que el sexo femenino y la edad avanzada influencian el aumento del riesgo. Las personas mayores de edad poseen 7,19 veces más probabilidades de tener un alto riesgo cardiovascular. Consideraciones finales e implicaciones para la práctica los pacientes hipertensos de edad avanzada tenían una prevalencia elevada de síndrome metabólico que aumentaba, considerablemente, el riesgo cardiovascular. Este resultado permite una mejor planificación de la atención de enfermería por parte de las enfermeras en la atención primaria de la salud.


ABSTRACT Objective To evaluate metabolic syndrome and cardiovascular risk for hypertensive elderly patients treated in primary care. Methods A cross-sectional study carried out with 154 hypertensive elderly from a Basic Health Unit in the Federal District. A structured instrument investigated the profile of the elderly. For classifying the metabolic syndrome, the criteria proposed by the National Cholesterol Education Program - Treatment Panel for Adults III were considered. For cardiovascular risk analysis, the Framingham risk score was used. Statistical and inferential analysis was performed using ANOVA, chi-square test and Fisher's exact test, in addition to Odds Ratio and its 95% confidence interval to estimate cardiovascular risk among the groups. Results 64.9% of the hypertensive elderly were obese. Metabolic syndrome was evidenced in 70.8%. It was noted that 27.2% had low, 46.8% moderate, and 26.0% high cardiovascular risk, and that being a woman and of advanced aged negatively influenced the risk. Older adults with metabolic syndrome showed 7.19 times more likelihood to have high cardiovascular risk. Final considerations and implications for the practice The hypertensive elderly patients had high metabolic syndrome prevalence, which significantly increased cardiovascular risk. This result allows for a better planning of nursing care by the nurses in primary health care.


Subject(s)
Humans , Male , Female , Aged , Primary Health Care , Metabolic Syndrome/epidemiology , Hypertension/epidemiology , Brazil/epidemiology , Chronic Disease/epidemiology , Prevalence , Risk Factors , Nurse Practitioners , Obesity/epidemiology
8.
Rev. cuba. med ; 59(4): e1561, oct.-dic. 2020. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1144506

ABSTRACT

Introducción: El síndrome metabólico es un importante problema de salud y factor de riesgo para un grupo de enfermedades cuyo factor patogénico común es la aterosclerosis. Estas enfermedades constituyen la primera causa de muerte en muchos países y también en Cuba. Objetivo: Caracterizar el perfil del síndrome metabólico en la población de dos consultorios. Método: Se realizó un estudio observacional, descriptivo y transversal en 2 consultorios médicos del policlínico Primero de enero. A los pacientes diagnosticados con síndrome metabólico se les realizó una medición del Índice de Masa Corporal y del colesterol total. Resultados: El síndrome metabólico se diagnosticó en 247 pacientes, su prevalencia en la población estudiada fue de 9,57 por ciento. 121 pacientes (49 por ciento del total) tenían 60 años o más. Los componentes del síndrome metabólico encontrados con mayor frecuencia fueron obesidad abdominal en 168 pacientes (68,01 por ciento de la muestra), hiperglucemia en 115 (46,56 por ciento) e hipertensión arterial en 98 (39,68 por ciento). 86 pacientes (34,82 por ciento) también presentaron hipercolesterolemia. Conclusiones: El síndrome metabólico se presenta frecuentemente en la población mayor de 60 años. La obesidad abdominal, la hiperglicemia y la hipertensión arterial son los componentes del síndrome metabólico hallados con mayor frecuencia. La hipercolesterolemia se detecta a menudo en pacientes con dicho síndrome. Para reducir la morbimortalidad relacionada con el síndrome metabólico es necesario establecer estrategias de detección y control eficaz de los factores de riesgo que lo componen y de la hiperlipidemia frecuentemente asociada(AU)


Introduction: The metabolic syndrome is an important health problem and risk factor for a group of diseases whose common pathogenic factor is atherosclerosis. These diseases are the leading cause of death in many countries, as well in Cuba. Objective: To characterize the profile of the metabolic syndrome in the population of two clinics. Method: An observational, descriptive and cross-sectional study was carried out in 2 medical clinics of Primero de Enero polyclinic. A measurement of the Body Mass Index and total cholesterol was performed in patients diagnosed with metabolic syndrome. Results: The metabolic syndrome was diagnosed in 247 patients; the prevalence in the studied population was 9.57 percent . One hundred twenty one patients (49 percent of the total) were 60 years or older. The most frequently found components of the metabolic syndrome were abdominal obesity in 168 patients (68.01 percent sample), hyperglycemia in 115 (46.56 percent) and arterial hypertension in 98 (39.68 percent). Eighty-six patients (34.82 percent) also had hypercholesterolemia. Conclusions: The metabolic syndrome frequently occurs in the population older than 60 years. Abdominal obesity, hyperglycemia, and high blood pressure are the most frequently found components of the metabolic syndrome. Hypercholesterolemia is often found in patients with this syndrome. In order to reduce the morbidity and mortality related to the metabolic syndrome, it is necessary to establish effective detection and control strategies of the risk factors and of the frequently associated hyperlipidemia(AU)


Subject(s)
Humans , Male , Female , Risk Factors , Metabolic Syndrome/epidemiology , Epidemiology, Descriptive , Cross-Sectional Studies
9.
Rev. Assoc. Med. Bras. (1992) ; 66(12): 1628-1632, Dec. 2020. tab
Article in English | SES-SP, LILACS, SES-SP | ID: biblio-1143667

ABSTRACT

SUMMARY OBJECTIVE: Hot flashes have a negative impact on the quality of life of women during the menopausal transition and thereafter. The progressive reduction in gonadal estrogen levels associated with aging promotes an accumulation of abdominal fat, dyslipidemia, and arterial hypertension, all of which are components of metabolic syndrome (MetS). The objective of the present study was to estimate the prevalence of hot flashes and evaluate their relationship with MetS in women ≥ 40 years of age. METHODS: This was a cross-sectional study involving women aged between 40 and 65 years. We used the Kupperman index to quantify the climacteric symptoms and the National Cholesterol Education Program Adult Treatment Panel III criteria for the diagnosis of MetS. RESULTS: 1,435 women were initially selected, and we obtained information from 647. The mean age at menopause was 45.99 years (SD 6.61 years) and the prevalence of hot flashes and MetS were 55.83% (95% CI: 52.35-59.25%) and 46.29% (95% CI: 44.75-52.53%), respectively. We identified a positive association between MetS and hot flashes (OR 1.16; 95% CI: 1.01-1.33). CONCLUSIONS: In women ≥ 40 years of age, hot flashes are highly prevalent and appear to be associated with MetS.


RESUMO OBJETIVO: As ondas de calor têm um impacto negativo na qualidade de vida das mulheres no climatério. A redução progressiva dos níveis de estrogênio gonadal associada ao envelhecimento promovem o acúmulo de gordura abdominal, dislipidemia e hipertensão arterial, componentes da síndrome metabólica (SM). O objetivo do presente estudo foi estimar a prevalência de ondas de calor e avaliar sua relação com SM em mulheres com idade ≥40 anos. MÉTODOS: Estudo transversal envolvendo mulheres entre 40 e 65 anos de idade. Utilizamos o índice de Kupperman para quantificar os sintomas climatéricos e os critérios do National Cholesterol Education Program Adult Treatment Panel III para o diagnóstico de SM. RESULTADOS: Mil, quatrocentas e trinta e cinco mulheres foram selecionadas inicialmente e obtivemos informações de 647. A idade média da menopausa foi de 45,99 anos (DP 6,61 anos) e a prevalência de ondas de calor e SM foi de 55,83% (95% CI: 52,35-59,25%) e 46,29% (95% CI: 44,75-52,53%), respectivamente. Identificamos uma associação positiva entre SM e ondas de calor (OR 1,16; IC95%: 1,01-1,33). CONCLUSÕES: Em mulheres com idade ≥40 anos, as ondas de calor são altamente prevalentes e parecem estar associadas a SM.


Subject(s)
Humans , Female , Adult , Aged , Hot Flashes/epidemiology , Metabolic Syndrome/epidemiology , Quality of Life , Menopause , Prevalence , Cross-Sectional Studies , Middle Aged
10.
Rev. cuba. enferm ; 36(4): e3269, tab
Article in Portuguese | LILACS, BDENF, CUMED | ID: biblio-1280290

ABSTRACT

Introdução: A síndrome metabólica constitui-se em um dos fatores de risco cardiovascular e as estratégias para seu enfrentamento são indispensáveis para reduzir a morbimortalidade da população. Objetivo: Identificar os diagnósticos de ernfermagem e intervenções realizadas nos cuidados a pessoa com síndrome metabólica submetida a gastrectomia. Métodos: Pesquisa descritiva do tipo intervenção no cuidado a pessoa com síndrome metabólica submetida à gastrectomia, acompanhada pelo serviço de Enfermagem, no período de 2016 a 2018, em uma Unidade Básica de Saúde no interior da Bahia. Os dados foram obtidos por meio de anamnese, exame físico e exames clinico-laboratoriais disponíveis no prontuário. Os dados foram armazenados em tabela única constando os dados antropométricos e os exames glicêmicos e lipídicos antes e após a cirurgia. Adotou-se como parâmetro avaliativo a análise clínica descritiva das evidências constatadas no exame físico e nos resultados dos exames laboratoriais, como parte da rotina profissional. Resultados: Traçou-se os seguintes diagnósticos: Ansiedade; Medo; Nutrição desequilibrada: mais que as necessidades corporais; conhecimento deficiente sobre a síndrome metabólica. No pós-operatório da gastrectomia traçou-se: risco de nutrição desequilibrada: menos que as necessidades corporais; risco de infecção; dor aguda e integridade da pele prejudicada. Conclusão: Após a cirurgia, houve redução dos índices que a classificava como portadora da Síndrome Metabólica. Os dados antropométricos e metabólicos demonstram que a paciente não tem mais a síndrome porque a obesidade, a alteração glicêmica e da pressão arterial foram revertidas e as medicações suspensas(AU)


Introducción: El síndrome metabólico constituye un factor de riesgo cardiovascular y las estrategias para enfrentarlo son esenciales para reducir la morbimortalidad de la población. Objetivo: Describir el proceso de enfermería en los cuidados a la persona con síndrome metabólico sometida a la gastrectomía. Métodos: Se trata de una investigación descriptiva de intervención en el cuidado a la persona con síndrome metabólico sometida a la gastrectomía, acompañada por el servicio de enfermería, en el período de 2016 a 2018, en una Unidad Básica de Salud en el interior de Bahía. Los datos se obtuvieron a través de anamnesis, examen físico y exámenes clínicos y de laboratorio disponibles en los registros médicos. Los datos se almacenaron en una sola tabla que contenía datos antropométricos y pruebas de glucemia y lípidos antes y después de la cirugía. El parámetro evaluativo fue el análisis clínico descriptivo de la evidencia encontrada en el examen físico y los resultados de las pruebas de laboratorio, como parte de la rutina profesional. Resultados: Fueron trazados los siguientes diagnósticos de enfermería: ansiedad; miedo; nutrición desequilibrada: más que las necesidades corporales; el conocimiento deficiente sobre el síndrome metabólico. En el postoperatorio de la gastrectomía fueron trazados: riesgo de nutrición desequilibrada: menos que las necesidades corporales; riesgo de infección; dolor agudo e integridad de la piel perjudicial. Conclusión: Después de la cirugía hubo una reducción en las tasas que la clasificaron como síndrome metabólico. Los datos antropométricos y metabólicos muestran que el paciente ya no tiene el síndrome porque la obesidad, la alteración de la glucosa en la sangre y la presión arterial se revirtieron y se suspendieron los medicamentos(AU)


Introduction: Metabolic syndrome constitutes the cardiovascular risk factors and the strategies for its confrontation are essential to reduce the morbimortality of the population. Objective: Identify nursing diagnoses and perform care for a person with metabolic syndrome undergoing gastrectomy. Methods: It is a descriptive study of type intervention in the care of the person with Metabolic Syndrome submitted to gastrectomy, accompanied by the Nursing service, from 2016 to 2018, in a Basic Health Unit in the interior of Bahia. Data were obtained through anamnesis, physical examination and clinical and laboratory exams available in the medical records. Data were stored in a single table containing anthropometric data and glycemic and lipid tests before and after surgery. The evaluative parameter was the descriptive clinical analysis of the evidence found in the physical examination and the results of laboratory tests, as part of the professional routine. The study was approved by the Research Ethics Committee under Opinion No. 2.850.239. Results: It were traced the Nursing diagnoses: Anxiety; Fear; Unbalanced nutrition: more than bodily needs; knowledge about the metabolic syndrome. In post-operative gastrectomy were traced: risk of unbalanced nutrition: less than the bodily needs; risk of infection; acute pain and impaired skin integrity. Conclusion: After surgery, there was a reduction in the rates that classified her as having Metabolic Syndrome. Anthropometric and metabolic data show that the patient no longer has the syndrome because obesity, glycemic alteration and blood pressure were reversed and medications were suspended(AU)


Subject(s)
Humans , Nursing Diagnosis/methods , Metabolic Syndrome/epidemiology , Gastrectomy/adverse effects , Nursing Process , Medical Records , Indicators of Morbidity and Mortality , Epidemiology, Descriptive
11.
Ciênc. Saúde Colet ; 25(11): 4269-4280, nov. 2020. tab, graf
Article in English, Portuguese | ColecionaSUS, LILACS, ColecionaSUS, SES-SP | ID: biblio-1133046

ABSTRACT

Resumo Estimou-se a prevalência de Síndrome Metabólica (SM) e seus componentes na população brasileira de acordo com fatores sociodemográficos. Estudo transversal, de base populacional, com dados laboratoriais da Pesquisa Nacional de Saúde. Estimou-se prevalência da SM e seus componentes com intervalos de 95% de confiança e Razão de Prevalência (RP) não ajustada e ajustada utilizando regressão de Poisson. A prevalência de SM foi de 38,4%. A circunferência da cintura (CC) alta (65,5%) e colesterol HDL baixo (49,4%) foram os componentes mais prevalentes, inclusive nos jovens. A ocorrência de SM foi maior entre mulheres (41,8%), indivíduos com baixa escolaridade (47,5%) e idosos (66,1%). Na análise ajustada, sexo feminino (RP = 1,16; IC95% 1,08-1,24), idade avançada (RP = 3,69; IC95% 3,26-4,17) e baixa escolaridade (RP = 1,32; IC95% 1,17-1,49) associaram-se à ocorrência de SM. A SM foi muito prevalente na população brasileira, principalmente entre mulheres, indivíduos com baixa escolaridade e idosos. A CC alta e o colesterol HDL baixo foram os componentes mais frequentes, com o agravante de prevalências altas em adultos jovens. Esses achados revelam a necessidade de considerar dados laboratoriais para uma análise mais precisa dessa condição, o que em âmbito nacional pode ser um desafio.


Abstract We estimated the prevalence of the Metabolic Syndrome (MetS) and its components in the Brazilian population according to sociodemographic factors. This is a cross-sectional population-based study that used laboratory data from the National Health Survey. We estimated the prevalence of MetS and its components with 95% confidence intervals and the unadjusted and adjusted prevalence ratio (PR) with the Poisson regression. MetS prevalence ratio was 38.4%. High waist circumference (WC) (65.5%) and low HDL cholesterol (49.4%) were the most prevalent components, including in the youngest people. MetS and its components were more frequent among women (41.8%), individuals with low schooling (47.5%), and older adults (66.1%). In the adjusted analysis, females (PR = 1.16; 95% CI 1.08-1.24), older adults (PR = 3.69; 95% CI 3.26-4.17), and low schooling (PR = 1.32; 95% CI 1.17-1.49) were associated with MetS. MetS was prevalent in the Brazilian population, especially among women, individuals with low schooling, and older adults. High WC and low HDL cholesterol were the most prevalent components, with the aggravating high prevalence factor in young adults. These findings reveal the need to consider laboratory data for a more accurate analysis of this condition, which can be challenging at the national level.


Subject(s)
Humans , Female , Aged , Young Adult , Metabolic Syndrome/epidemiology , Brazil/epidemiology , Prevalence , Cross-Sectional Studies , Risk Factors , Waist Circumference
12.
Rev. habanera cienc. méd ; 19(5): e3698, sept.-oct. 2020. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1144684

ABSTRACT

RESUMEN Introducción: El Síndrome Metabólico triplica el riesgo de desarrollar enfermedad cardiovascular. Se asocia a la obesidad y a estilos de vida poco saludables. Constituye uno de los principales factores de riesgo aterogénico por lo que es imprescindible su diagnóstico precoz a nivel de la atención primaria de salud. Objetivo: Determinar el comportamiento del Síndrome Metabólico en personas mayores de 60 años de las tres casas de abuelos del municipio Boyeros. Material y Métodos: Se realizó un estudio observacional descriptivo de corte transversal. El universo de estudio lo constituyeron 130 personas, de ellas se entrevistaron a 103 de las personas en el período de enero de 2016 a febrero de 2017. Se siguieron los criterios del Adult Treatment Panel III para el diagnóstico de Síndrome Metabólico. Las variables descriptivas se expresaron en por cientos y para la comparación de variables en estudio se utilizó el método estadístico de chi cuadrado. Resultados: Los resultados obtenidos mostraron 33,01 por ciento de pacientes con Síndrome Metabólico, predominó el grupo de edad de 60 a 64 años con 44,12 por ciento y el sexo femenino con 64,71 por ciento. El 97,06 por ciento tienen cifras de presión arterial ≥ 130/85 mmHg. El 100 por ciento de los pacientes desconocían su enfermedad. Conclusiones: Se encontró predominio en los pacientes con Síndrome Metabólico del sexo femenino y del grupo de edad de 60 a 64 años. El diagnóstico a nivel de la Atención Primaria de Salud es deficiente. Se asocia a la obesidad abdominal y al riesgo de enfermedad cardiovascular(A)


ABSTRACT Introduction: Metabolic Syndrome triples the risk of developing cardiovascular disease. It is associated with obesity and unhealthy lifestyles. This syndrome is one of the main atherogenic risk factors; consequently, its early diagnosis at the primary health care level is essential. Objective: To deterine the manifestations of the Metabolic Syndrome in people over 60 years of age in three elderly homes in Boyeros Municipality. Material and Methods: A descriptive observational cross-sectional study was carried out. The study universe consisted of 130 people, 103 of whom were interviewed during the period between January 2016 and February 2017.The criteria of the Adult Treatment Panel III were followed for the diagnosis of Metabolic Syndrome. Descriptive variables were expressed in percentages and the chi-square statistic was used to compare the study variables. Results: The results obtained showed that 33.01 percent of patients were suffering from Metabolic Syndrome, predominating the people aged 60 to 64 years (44.12 percent) and the female sex (64.71 percent). Furthermore, 97.06 percent presented blood pressures ≥130/85 mmHg and 100 percent of patients had no knowledge of their disease. Conclusions: Metabolic Syndrome predominated in female patients and in those aged 60 to 64 years. The early diagnosis at the primary health care level is poor. This syndrome is associated with abdominal obesity and the risk of cardiovascular disease(AU)


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Metabolic Syndrome/epidemiology , Homes for the Aged , Epidemiology, Descriptive , Cross-Sectional Studies , Observational Study
13.
Medisan ; 24(4)jul.-ago. 2020. tab
Article in English | LILACS, CUMED | ID: biblio-1125140

ABSTRACT

Introduction: The metabolic syndrome is defined by the presence of obesity, fundamentally central, hypertension, diabetes mellitus, and dyslipidemia; Objective: To characterize patients with metabolic syndrome from the clinical and epidemiological points of view. Methods: A descriptive and prospective study of 640 patients with metabolic syndrome was carried out, who were admitted to Dr. Juan Bruno Zayas Alfonso Teaching General Hospital from Santiago de Cuba during 2019. Information was statistically processed and analyzed; through the SPSS 11.5.1 program, by using the percentage as summary measure for qualitative variables. Results: In the serie, 26.8% of the patients belonged to the age group 40-49, and 53,0% were of female sex. Likewise, diabetes mellitus and hypertension were the associated diseases in 22,3 y 22,2 % of the patients, respectively, while 67,7 % had a saturated fats diet. Social drinkers were identified in 53,0 % of cases, and the heavy smokers in 47.0 %. Conclusions: Personal and family associated diseases prevailed as associated personal and family diseases, what shows the closed relationship between them and the metabolic syndrome. Health promotion and education should be considered in patients with metabolic syndrome from the primary care, as well as the distribution of medical care for this group of hospital institutions, to prevent and control risk factors related to its emergence.


Introducción: El síndrome metabólico está definido por la presencia de obesidad, fundamentalmente central; hipertensión arterial; diabetes mellitus y dislipidemias. Objetivo: Caracterizar a pacientes con síndrome metabólico desde el punto de vista clínico-epidemiológico. Métodos: Se realizó un estudio descriptivo y prospectivo de 640 pacientes con síndrome metabólico atendidos en el Hospital General Docente Dr. Juan Bruno Zayas Alfonso de Santiago de Cuba durante el año 2019. La información se procesó y analizó estadísticamente mediante el programa SPSS 11.5.1, con el empleo del porcentaje como medida de resumen para variables cualitativas. Resultados: En la serie, 26,8 % perteneció al grupo de edades de 40-49 años y 53,0 % era del sexo femenino. Asimismo, la diabetes mellitus y la hipertensión arterial figuraron como enfermedades asociadas en 22,3 y 22,2 % de los pacientes, respectivamente, en tanto 67,7 % ingería dieta a base de grasa saturada. Los bebedores sociales fueron identificados en 53,0 % de los casos y los fumadores empedernidos en 47,0 %. Conclusiones: La diabetes mellitus y la hipertensión arterial predominaron como enfermedades personales y familiares asociadas, lo que muestra la estrecha relación entre estas y el síndrome metabólico. Deben considerarse la educación y promoción de salud en pacientes con síndrome metabólico desde la atención primaria, así como la verticalización de la atención médica para este grupo en instituciones hospitalarias, a fin de prevenir y controlar los factores de riesgo relacionados con su aparición.


Subject(s)
Metabolic Syndrome/epidemiology , Diabetes Mellitus , Obesity, Abdominal , Dyslipidemias , Hypertension
14.
Medicina (B.Aires) ; 80(5): 453-461, ago. 2020. graf
Article in Spanish | LILACS | ID: biblio-1287198

ABSTRACT

Resumen La enfermedad cardiovascular y sus factores de riesgos como hipertensión arterial (HTA) y síndrome metabólico (SM), son una creciente causa de mortalidad entre los infectados con HIV. Nuestros objetivos fueron determinar la prevalencia HTA y SM en pacientes HIV positivos de la ciudad de Córdoba su asociación con el estado inmunológico, inflamación y terapia antirretroviral (TARAA). Fue un estudio aleatorizado de corte transversal. Se incluyeron 65 pacientes HIV positivos del programa provincial HIV-Córdoba, 57 (87%) recibían TARAA, 39 (60%) eran masculinos, con edad promedio de 44.7 ± 10 años. La concentración de linfocitos T CD4+ (LTCD4+) fue 404.4 ± 289.6 cel./ml. La carga viral (CV) fue indetectable en 56 (86.2%). La prevalencia de HTA fue de 40% (26/65) y se asoció a la duración de TARAA (p < 0.05). No hubo asociación entre años de infección por HIV, LTCD4+ y CV con HTA. La prevalencia de SM fue de 38.5% (25/65). El uso de TARAA fue más frecuente en aquellos con SM (OR: 1.80; IC95%: 1.43-2.28; p = 0.02). Pacientes bajo TARAA presentaron alta tasa de hipertrigliceridemia, intolerancia a la glucosa y niveles bajos de HDL (todos p < 0.01). SM se asoció a la duración de TARAA (p < 0.01). La TARAA se asoció a HTA y SM, no encontrándose relación con estado inmunológico, CV o marcadores de inflamación.


Abstract Cardiovascular diseases (CVD) are a growing cause of mortality between human immunodeficiency virus (HIV) infected patients. Hypertension (HTN) and metabolic syndrome (MS) are important causes of CVD. The prevalence of HTN and MS in HIV infected patients in Córdoba, Argentina is unknown. Our aim is to determine the prevalence of HTN and MS in HIV patients in Córdoba and their association with immunological state, inflammation and highly active antiretroviral therapy (HAART) in an observational study. Sixty-five HIV infected patients from the provincial HIV program were randomly selected. Fifty-seven (87%) were on HAART, 39 (60%) were males. The mean age was 44.7 ± 10 years. Mean CD4+ T lymphocytes (CD4+T) count was 404.4 ± 289.6 cells/ml. Viral load (VL) was undetectable in 56 (86.2%). The prevalence of HTN was 40%, and it was associated with the duration of HAART (p < 0.05). There was no association between years of HIV infection, CD4+T, VL and blood pressure. The prevalence of MS was 38.5% (25/65). MS was more frequent between those with HAART (OR: 1.80; CI 95%; 1.43-2.28; p = 0.02). Patients on HAART had higher rates of hypertriglyceridemia, impaired glucose tolerance and lower levels of HDLc (p < 0.01). MS was associated with the HAART duration (p < 0.01). HIV infected patients had a high prevalence of HTN and MS. HAART was associated with both HTN and MS, but there was no association between immunological status, VL or inflammatory markers.


Subject(s)
Humans , Male , Adult , Middle Aged , HIV Infections/epidemiology , Hypertension/epidemiology , Argentina/epidemiology , HIV Infections/complications , HIV Infections/drug therapy , Antiretroviral Therapy, Highly Active , Metabolic Syndrome/epidemiology
15.
An. bras. dermatol ; 95(2): 165-172, Mar.-Apr. 2020. tab
Article in English | ColecionaSUS, LILACS, ColecionaSUS | ID: biblio-1130836

ABSTRACT

Abstract Background/Objectives: To investigate the association between vitiligo and metabolic syndrome. Methods: A prospective cross-sectional study was conducted between 2014 and 2016. Study (n = 155) and control groups (n = 155) were evaluated for metabolic syndrome according to National Cholesterol Education Program Adult Treatment Panel III and the International Diabetes Federation criteria. Study group was divided into three groups according to their vitiligo area severity index and vitiligo disease activity score values (Group 1: 6.89 for VASI score, Group A: −1-0, Group B: 1-2 and Group C: 3-4 for vitiligo disease activity score respectively). MetS rates according to both criteria were compared between the vitiligo disease activity score and vitiligo area severity index groups. Results: Metabolic syndrome rates were 37.4% and 40% in the study group and 19.4% and 26.5% in the control group according to National CholesterolEducation Program Adult Treatment Panel III and International Diabetes Federation criteria, respectively (p < 001 and p = 0.011). Metabolic syndrome was more frequent in vitiligo area severity index Groups 2 and 3 compared to vitiligo area severity index Group 1, and in vitiligo disease activity score Group C compared to vitiligo disease activity score Groups A and B. Study limitations: Single center experience, absence of more specific oxidative-stress markers and lack of long-term follow-up of the patients. Conclusions: Frequency of metabolic syndrome was higher in patients with non-segmental vitiligo and the rate was higher in active/severe form of the disease.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Aged , Young Adult , Metabolic Syndrome/epidemiology , Reference Values , Turkey/epidemiology , Vitiligo/complications , Vitiligo/blood , Vitamin B 12 Deficiency/blood , Severity of Illness Index , Incidence , Cross-Sectional Studies , Prospective Studies , Risk Factors , Sex Distribution , Statistics, Nonparametric , Metabolic Syndrome/complications , Metabolic Syndrome/blood , Middle Aged
17.
Chinese Medical Journal ; (24): 8-19, 2020.
Article in English | WPRIM | ID: wpr-877973

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, placing an increasing burden on human health. NAFLD is a complex multifactorial disease involving genetic, metabolic, and environmental factors. It is closely associated with metabolic syndrome, obesity, and type 2 diabetes, of which insulin resistance is the main pathophysiological mechanism. Over the past few decades, investigation of the pathogenesis, diagnosis, and treatments has revealed different aspects of NAFLD, challenging the accuracy of definition and therapeutic strategy for the clinical practice. Recently, experts reach a consensus that NAFLD does not reflect the current knowledge, and metabolic (dysfunction) associated fatty liver disease (MAFLD) is suggested as a more appropriate term. The new definition puts increased emphasis on the important role of metabolic dysfunction in it. Herein, the shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy of the newly defined MAFLD, as compared with the formerly defined NAFLD, are reviewed for updating our understanding.


Subject(s)
Diabetes Mellitus, Type 2/epidemiology , Humans , Insulin Resistance , Metabolic Syndrome/epidemiology , Non-alcoholic Fatty Liver Disease/epidemiology , Obesity
18.
Chinese Medical Journal ; (24): 2688-2695, 2020.
Article in English | WPRIM | ID: wpr-877836

ABSTRACT

BACKGROUND@#Metabolic syndrome (MetS) is relatively common worldwide and an important risk factor for cardiovascular diseases. It is closely linked to arterial stiffness of the carotid artery. However, the association of MetS with the safety of carotid revascularization has been rarely studied. The aim of this study was to observe the current status of MetS and its components in Chinese carotid revascularized patients, and investigate the impact on major adverse clinical events (MACEs) after carotid endarterectomy (CEA) or carotid artery stenting (CAS).@*METHODS@#From January 2013 to December 2017, patients undergoing CEA or CAS in the Neurosurgery Department of Xuanwu Hospital were retrospectively recruited. The changes in prevalence of MetS and each component with time were investigated. The primary outcome was 30-day post-operative MACEs. Univariable and multivariable analyses were performed to identify the impact of MetS on CEA or CAS.@*RESULTS@#A total of 2068 patients who underwent CEA (766 cases) or CAS (1302 cases) were included. The rate of MetS was 17.9%; the prevalence rate of MetS increased with time. The occurrence rate of MACEs in CEA was 3.4% (26 cases) and in CAS, 3.1% (40 cases). There was no statistical difference between the two groups (3.4% vs. 3.1%, P = 0.600). For CEA patients, univariate analysis showed that the MACE (+) group had increased diabetes history (53.8% vs. 30.9%, P = 0.014) and MetS (34.6% vs. 15.8%, P = 0.023). For CAS patients, univariate analysis showed that the MACE (+) group had increased coronary artery disease history (40.0% vs. 21.6%, P = 0.006) and internal carotid artery tortuosity (67.5%% vs. 37.6%, P < 0.001). Furthermore, the MACE (+) group had higher systolic blood pressure (143.38 ± 22.74 vs. 135.42 ± 17.17 mmHg, P = 0.004). Multivariable analysis showed that the influencing factors for MACEs in CEA included history of diabetes (odds ratio [OR] = 2.345; 95% confidence interval [CI] = 1.057-5.205; P = 0.036) and MetS (OR = 2.476; 95% CI = 1.065-5.757; P = 0.035). The influencing factors for MACEs in CAS included systolic blood pressure (OR = 1.023; 95% CI = 1.005-1.040; P = 0.010), coronary artery disease (OR = 2.382; 95% CI = 1.237-4.587; P = 0.009) and internal carotid artery tortuosity (OR = 3.221; 95% CI = 1.637-6.337; P = 0.001).@*CONCLUSIONS@#The prevalence rate of MetS increased with time in carotid revascularized patients. MetS is a risk for short-term MACEs after CEA, but not CAS.


Subject(s)
Carotid Arteries/surgery , Carotid Stenosis/surgery , China/epidemiology , Endarterectomy, Carotid/adverse effects , Humans , Metabolic Syndrome/epidemiology , Retrospective Studies , Risk Factors , Sample Size , Stents/adverse effects , Stroke , Time Factors , Treatment Outcome
19.
Rev. bras. epidemiol ; 23: e200046, 2020. tab, graf
Article in Portuguese | LILACS | ID: biblio-1101585

ABSTRACT

RESUMO: Objetivo: Avaliar a associação da síndrome metabólica (SM) com a atividade física e as condições socioeconômicas entre idosos não institucionalizados. Metodologia: Estudo transversal com idosos (≥ 60) não institucionalizados e residentes na cidade de São Paulo (SP). A SM foi classificada com base nos critérios da National Cholesterol Education Program Adult Treatment Panel III. Realizou-se analise descritiva e bivariada seguida por regressão logística múltipla com nível de significância de 5%. Calcularam-se a fração atribuível (FA) e a fração atribuível proporcional (FAP) e determinou-se a magnitude das desigualdades por meio do índice absoluto de desigualdade e pelo índice relativo de desigualdade. Resultados: A prevalência de SM foi de 40,1%, e 23,3% dos idosos apresentavam pelo menos um componente da síndrome. A chance de SM foi maior entre os idosos fisicamente inativos. Idosos menos escolarizados apresentaram prevalências de SM significativamente maiores em termos absolutos e relativos. As FA e FAP entre os inativos e na população foram significativos. Conclusão: Este estudo demonstrou que a prática de atividade física e a escolaridade são fatores significativamente associados à SM, reforçando a importância desses fatores para o controle dessa síndrome.


ABSTRACT: Objective: Evaluate the association between Metabolic Syndrome (MetS), physical activity and socioeconomic conditions among non-institutionalized elderly individuals. Methodology: Cross-sectional study with, elderly individuals (≥ 60) living in the city of São Paulo. MetS was evaluated by means of the National Cholesterol Education Program criteria, the Adult Treatment Panel III. Descriptive and bivariate analyses were performed, followed by multiple logistic regression with a 5% significance level. An attributable fraction (AF) and a proportional attributable fraction (PAF) were calculated in relation to physical activity. The magnitude of the socioeconomic inequalities was evaluated using the Slope Index of Inequality (SII) and the Relative Index of Inequality (RII). Results: The prevalence of MetS was 40.1%, and 23.3% of the individuals had at least one MetS' component. Physically inactive elderly had higher chances of having MetS. The prevalence of MetS was higher among those with lower education levels in both absolute and relative terms. AF and PAF were significant among the inactive individuals and for the total population. Conclusion: This study demonstrated that physical activity and schooling are significantly associated with MetS, highlighting the importance of these factors for the control of this syndrome.


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Socioeconomic Factors , Metabolic Syndrome/epidemiology , Sedentary Behavior , Brazil/epidemiology , Geriatric Assessment , Logistic Models , Prevalence , Cross-Sectional Studies , Risk Factors , Sex Distribution , Age Distribution , Metabolic Syndrome/prevention & control , Health Status Disparities , Middle Aged
20.
Dermatol. argent ; 26(1): 17-22, 2020. ilus, tab, graf
Article in Spanish | LILACS | ID: biblio-1146358

ABSTRACT

Antecedentes: La hidradenitis supurativa (HS) es una enfermedad inflamatoria crónica relacionada con el síndrome metabólico (SM), con un mayor riesgo de comorbilidades cardiovasculares; por lo tanto, se debe mantener un alto grado de sospecha clínica frente al hallazgo de alguno de sus componentes. Objetivo: Evaluar la prevalencia del SM en los pacientes con diagnóstico de HS en comparación con la población general. Diseño: Estudio retrospectivo descriptivo. Métodos: Se revisaron las historias clínicas y el archivo fotográfico de los pacientes con diagnóstico de HS que consultaron entre el 1/9/2017 y el 31/8/2019. Se analizaron las variables: sexo, edad, antecedentes familiares, tiempo de evolución, índice de masa corporal, obesidad abdominal, laboratorio (glucemia y perfil lipídico), presión arterial, tabaquismo, número y localización de las lesiones, gravedad clinicoecográfica, respuesta al tratamiento y evolución clínica. Resultados: Se evaluaron 30 pacientes con HS valorados en nuestro servicio en los últimos 2 años; 23 mujeres y 7 varones. Predominó el grupo etario de 31-40 años. De ellos, 19 pacientes (63,3%) cumplieron con los criterios necesarios para diagnosticar el SM, hallazgo que no se relacionó con el grado de severidad de la HS. Conclusiones: La prevalencia del SM en nuestros pacientes con HS fue del 63,3% con respecto al 27,5% de la población general. La importancia de este hallazgo radica en detectar de forma temprana y oportuna la presencia de este síndrome en los pacientes con HS para evitar el riesgo de comorbilidades cardiovasculares en el futuro. (AU)


Background: Suppurative hidradenitis (SH) is a chronic, inflammatory disease, closely related to metabolic syndrome (MS), with an increased risk of cardiovascular comorbidities; for that reason we should keep a high level of clinical suspicion when one of its components is found. Objective: To evaluate MS prevalence in patients with diagnosis of SH in comparison with general population. Design: Descriptive retrospective study. Methods: We reviewed clinical and photographical files of patients with diagnosis of suppurative hidradenitis who consulted from 1/9/2017 until 31/8/2019. Variables analyzed were: sex, age, familial history, time of evolution, body mass index, abdominal obesity, glycemia, lipid profile, blood pressure, smoking, number and location of lesions, clinicalechographic severity, response to treatment and clinical evolution. Results: Thirty patients with SH were evaluated, 23 females and 7 males. The age group between 31-40 years prevailed; of these, 19 patients (63.3%) meet necessary criteria for diagnosis of MS, this finding did not correlate to the severity degree of SH. Conclusions: The MS prevalence in our SH patients was 63.3%, compared to 27.5% in the general population. The importance of this finding lays on detecting in an early and opportune way, the presence of MS in patients with SH, and to avoid the risk of future cardiovascular comorbidities. (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Hidradenitis Suppurativa/complications , Metabolic Syndrome/complications , Metabolic Syndrome/epidemiology , Tobacco Use Disorder/complications , Body Mass Index , Prevalence , Retrospective Studies , Hidradenitis Suppurativa/diagnosis , Obesity, Abdominal/complications , Heart Disease Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL